Pathophysiologic cascades in ischemic stroke

Onlinelibrary.wiley.com: 6/19/12. Many advances have been achieved in terms of understanding the molecular and cellular mechanisms of ischemic stroke. But thus far, clinically effective neuroprotectants remain elusive. In this minireview, we summarize the basics of ischemic cascades after stroke, covering neuronal death mechanisms, white matter pathophysiology, and inflammation with an emphasis on microglia. Translating promising mechanistic […]

The influence of stroke risk factors and comorbidities on assessment of stroke therapies in humans and animals

Onlinelibrary.wiley.com: 6/19/12. The main driving force behind the assessment of novel pharmacological agents in animal models of stroke is to deliver new drugs to treat the human disease rather than to increase knowledge of stroke pathophysiology. There are numerous animal models of the ischaemic process and it appears that the same processes operate in humans. Yet, […]

Poststroke infections are an independent risk factor for poor functional outcome after three-months in thrombolysed stroke patients

Onlinelibrary.wiley.com: 5/28/12. Infections are common complications in patients with acute ischemic stroke; however, the pathophysiology of the stroke-induced immunodepression is still under debate. Although it has been shown that increased mortality and longer hospital stay are associated with the presence of poststroke infections, it remains unclear if early poststroke infections occurring in the first seven-days have […]

Intravenous thrombolysis for acute ischemic stroke patients presenting with mild symptoms

Onlinelibrary.wiley.com: 5/9/12. Our cohort included 1398 consecutive ischemic stroke patients treated with intravenous thrombolysis at the Helsinki University Central Hospital, years 1995–2010. We analyzed the patients according to baseline National Institutes of Health Stroke Scale: ≤2, 3–4, 5–6, and >6. In our institution, visualization of an artery occlusion or perfusion deficit is required for thrombolysis with […]

Risks of Intracranial Hemorrhage Among Patients With Acute Ischemic Stroke Receiving Warfarin and Treated With Intravenous Tissue Plasminogen Activator

Jama.jamanetwork.com: June 27, 2012, Vol 307, No. 24 Context  Intravenous tissue plasminogen activator (tPA) is known to improve outcomes in ischemic stroke; however, patients receiving long-term chronic warfarin therapy may face an increased risk for intracranial hemorrhage when treated with tPA. Although current guidelines endorse administering intravenous tPA to warfarin-treated patients if their international normalized ratio […]

Statin Therapy in the Prevention of Recurrent Cardiovascular Events

A Sex-Based Meta-analysis Archinte.jamanetwork.com: June 25, 2012 Background  The effect of statins on the prevention of cardiovascular events is well demonstrated. Whether this protective effect is equal for women and men remains less well established. Our objective was to evaluate if statin therapy is equally effective in decreasing recurrent cardiovascular events in women and men. Data […]

What the SWIFT and TREVO II Trials Tell Us About the Role of Endovascular Therapy for Acute Stroke” in both

Stroke.ahajournals.org: May 29, 2012 Revascularization of Collaterals for Hemodynamic Stroke Insight on Pathophysiology From the Carotid Occlusion Surgery Study Carotid atherosclerosis accounts for up to 15% of all strokes1 and approximately 15 000 to 20 000 have symptomatic carotid occlusions in the United States each year.2 Furthermore, recurrent ipsilateral stroke in unselected patients with carotid occlusion affects 2.1% […]

Times From Symptom Onset to Hospital Arrival in the Get With The Guidelines–Stroke Program 2002 to 2009

Stroke.ahajournals.org: April 26, 2012. Background and Purpose—Time from symptom onset to hospital arrival is the most important factor in determining eligibility for intravenous tissue-type plasminogen activator. We used data from a large contemporary nationwide study to determine temporal trends in the proportions of patients arriving within time windows for potential acute ischemic stroke therapies. Methods—Trends in […]

Clinical Outcomes Using a Platelet Function-Guided Approach for Secondary Prevention in Patients With Ischemic Stroke or Transient Ischemic Attack

Stroke.ahajournals.org: June 19, 2012. Antiplatelet therapy nonresponse is associated with worse clinical outcomes. We studied the clinical outcomes associated with platelet function-guided modifications in antiplatelet therapy in patients with ischemic stroke or transient ischemic attack. Methods—From January 2005 to August 2007, 324 patients with ischemic stroke underwent platelet function testing using platelet aggregometry. Aspirin nonresponse was […]

Effects of Repetitive Transcranial Magnetic Stimulation on Motor Functions in Patients With Stroke

Stroke.ahajournals.org: June 19, 2012. The purpose of this study was to perform a meta-analysis of studies that investigated the effects of repetitive transcranial magnetic stimulation (rTMS) on upper limb motor function in patients with stroke. Methods—We searched for randomized controlled trials published between January 1990 and October 2011 in PubMed, Medline, Cochrane, and CINAHL using the […]

National Minority Quality Forum
Clinical Trial Engagement Network Map Childhood Obesity MapHIV Z-Atlas: Peripheral Arterial Disease Atlas Map Lung Cancer Index Z-Atlas: Chronic Kidney Disease AFIB Index Cardiometabolic Health Aliance Minority Diabetes Coalition U.S. Diabetes Index County Edition U.S. Diabetes Index Research Edition Medicare Index Medicare Index Stroke Edition About The Minority Stroke Working Group Hepatitis C Disease Index Lead Risk Index Map MRSA StrokePAD Minority Index The South Texas Diabetes Initiative Minority Stroke Consortium YouTube NMQF Videos IPAB Action Center National Health Index

© 2011 National Minority Quality Forum, Inc. All Rights Reserved.